Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Health Aff (Millwood). 2019 Nov;38(11):1927–1935. doi: 10.1377/hlthaff.2019.00304

Exhibit 2.

Exhibit 2

Exhibit 2

CAPTION A. Differential changes in appropriate and low-value cancer screening associated with AWV exposure B. Differential changes in health care utilization associated with AWV exposure

SOURCE Authors’ beneficiary-level analysis of 20 percent Medicare claims data

NOTES CRC is colorectal cancer. Pap is Papanicolaou. PSA is prostate specific antigen. ED is emergency department. ACSC is ambulatory care sensitive conditions. This figure displays data also shown in Exhibit 2. Both models controlled for beneficiary characteristics (age, sex, race, dual enrollment in Medicaid, Hierarchical Condition Category score), practice characteristics (geographic setting, hospital-based vs independent site, specialty mix, size, number of attributed Medicare beneficiaries), geography at the level of hospital referral region (HRR), and the interaction between beneficiary characteristics and year and between HRR and year. The model “with pre-intervention trend” also included a term for AWV adoption interacted with a continuous year variable.